We are very pleased to announce that Dr. Andreas Penk joins the Board of Directors at Cureteq AG.
Andreas Penk, MD by education, is a former Senior Executive with Pfizer, most recently as President, Pfizer Pharmaceuticals Group China, and also held responsibility as Regional President (Oncology) at Pfizer for international developed markets (50+ countries). Andreas is also former Chair of the Board at the AI company, Innoplexus, and is co-founder of European Biopharma Therapeutics. Andreas Penk brings a wealth of experience and expertise to the table within development and commercial strategy, of great value as Cureteq seeks to expand our portfolio of assets in oncology and beyond.
For setting up meeting at J.P. Morgan 2024, San Francisco
